181 related articles for article (PubMed ID: 8609994)
1. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I.
Rossi F; Labourier E; Forné T; Divita G; Derancourt J; Riou JF; Antoine E; Cathala G; Brunel C; Tazi J
Nature; 1996 May; 381(6577):80-2. PubMed ID: 8609994
[TBL] [Abstract][Full Text] [Related]
2. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
3. Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor.
Labourier E; Rossi F; Gallouzi IE; Allemand E; Divita G; Tazi J
Nucleic Acids Res; 1998 Jun; 26(12):2955-62. PubMed ID: 9611241
[TBL] [Abstract][Full Text] [Related]
4. The [U4/U6.U5] tri-snRNP-specific 27K protein is a novel SR protein that can be phosphorylated by the snRNP-associated protein kinase.
Fetzer S; Lauber J; Will CL; Lührmann R
RNA; 1997 Apr; 3(4):344-55. PubMed ID: 9085842
[TBL] [Abstract][Full Text] [Related]
5. Identification of an snRNP-associated kinase activity that phosphorylates arginine/serine rich domains typical of splicing factors.
Woppmann A; Will CL; Kornstädt U; Zuo P; Manley JL; Lührmann R
Nucleic Acids Res; 1993 Jun; 21(12):2815-22. PubMed ID: 8332490
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing.
Xiao SH; Manley JL
Genes Dev; 1997 Feb; 11(3):334-44. PubMed ID: 9030686
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation status of the Kep1 protein alters its affinity for its protein binding partner alternative splicing factor ASF/SF2.
Robard C; Daviau A; Di Fruscio M
Biochem J; 2006 Nov; 400(1):91-7. PubMed ID: 16834570
[TBL] [Abstract][Full Text] [Related]
8. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
Cao W; Jamison SF; Garcia-Blanco MA
RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
[TBL] [Abstract][Full Text] [Related]
9. Thiophosphorylation of U1-70K protein inhibits pre-mRNA splicing.
Tazi J; Kornstädt U; Rossi F; Jeanteur P; Cathala G; Brunel C; Lührmann R
Nature; 1993 May; 363(6426):283-6. PubMed ID: 8387646
[TBL] [Abstract][Full Text] [Related]
10. cdc2 kinase-mediated phosphorylation of splicing factor SF2/ASF.
Okamoto Y; Onogi H; Honda R; Yasuda H; Wakabayashi T; Nimura Y; Hagiwara M
Biochem Biophys Res Commun; 1998 Aug; 249(3):872-8. PubMed ID: 9731229
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) binds to the splicing factor ASF/SF2 and regulates its phosphorylation by DNA topoisomerase I.
Malanga M; Czubaty A; Girstun A; Staron K; Althaus FR
J Biol Chem; 2008 Jul; 283(29):19991-8. PubMed ID: 18495665
[TBL] [Abstract][Full Text] [Related]
12. Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I.
Soret J; Gabut M; Dupon C; Kohlhagen G; Stévenin J; Pommier Y; Tazi J
Cancer Res; 2003 Dec; 63(23):8203-11. PubMed ID: 14678976
[TBL] [Abstract][Full Text] [Related]
13. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.
Colwill K; Pawson T; Andrews B; Prasad J; Manley JL; Bell JC; Duncan PI
EMBO J; 1996 Jan; 15(2):265-75. PubMed ID: 8617202
[TBL] [Abstract][Full Text] [Related]
14. SR proteins escort the U4/U6.U5 tri-snRNP to the spliceosome.
Roscigno RF; Garcia-Blanco MA
RNA; 1995 Sep; 1(7):692-706. PubMed ID: 7585254
[TBL] [Abstract][Full Text] [Related]
15. Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells.
Eisenreich A; Bogdanov VY; Zakrzewicz A; Pries A; Antoniak S; Poller W; Schultheiss HP; Rauch U
Circ Res; 2009 Mar; 104(5):589-99. PubMed ID: 19168442
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation-dephosphorylation differentially affects activities of splicing factor ASF/SF2.
Xiao SH; Manley JL
EMBO J; 1998 Nov; 17(21):6359-67. PubMed ID: 9799243
[TBL] [Abstract][Full Text] [Related]
17. The RNA splicing factor ASF/SF2 inhibits human topoisomerase I mediated DNA relaxation.
Andersen FF; Tange TØ; Sinnathamby T; Olesen JR; Andersen KE; Westergaard O; Kjems J; Knudsen BR
J Mol Biol; 2002 Sep; 322(4):677-86. PubMed ID: 12270705
[TBL] [Abstract][Full Text] [Related]
18. SF2/ASF protein inhibits camptothecin-induced DNA cleavage by human topoisomerase I.
Kowalska-Loth B; Girstun A; Piekiełko A; Staroń K
Eur J Biochem; 2002 Jul; 269(14):3504-10. PubMed ID: 12135490
[TBL] [Abstract][Full Text] [Related]
19. Poisoning of topoisomerase I by an antitumor indolocarbazole drug: stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activity.
Labourier E; Riou JF; Prudhomme M; Carrasco C; Bailly C; Tazi J
Cancer Res; 1999 Jan; 59(1):52-5. PubMed ID: 9892183
[TBL] [Abstract][Full Text] [Related]
20. Ordered multi-site phosphorylation of the splicing factor ASF/SF2 by SRPK1.
Ma CT; Velazquez-Dones A; Hagopian JC; Ghosh G; Fu XD; Adams JA
J Mol Biol; 2008 Feb; 376(1):55-68. PubMed ID: 18155240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
